Schonfeld Strategic Advisors’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
EIG
Schonfeld Strategic Advisors's TWST Position: Q2 2026 in Review
Schonfeld Strategic Advisors sold out of Twist Bioscience (TWST) in Q2 2026, closing a stake of 258,604 shares — an estimated $12.3M sold.
Schonfeld Strategic Advisors first reported a position in TWST in Q4 2018 and held it in 18 quarters. The position peaked at $14M in Q2 2019. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.
- Schonfeld Strategic Advisors reported no remaining Twist Bioscience position as of Q2 2026 after selling out during the quarter.
- Schonfeld Strategic Advisors sold 258,604 Twist Bioscience shares in Q2 2026, an estimated $12.3M.
- Schonfeld Strategic Advisors first reported a position in Twist Bioscience in Q4 2018 and held it in 18 quarters.
- Schonfeld Strategic Advisors's Twist Bioscience position peaked at $14M in Q2 2019.
- 338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.